Detection of K14 in Bladder Cancer With a Non Invasive Technique

N/ATerminatedNCT02027649

Corporacion Parc Tauli400 enrolled

Overview

By an invasive technique keratin 14 has been identified as a prognostic factor in bladder cancer. This study aims to analyze whether through a non-invasive technique keratin 14 can be used as a diagnostic and prognostic marker for this cancer.

Study Type

OBSERVATIONAL

Enrollment

400

Conditions

Bladder Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Bladder cancer Exclusion Criteria: * Inability to sign the informed consent

Locations (1)

Corporació Sanitària i Universitària Parc Taulí

Sabadell, Barcelona, Spain

Outcomes

Primary Outcomes

Keratin 14

Time frame: At the time of study entry

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.